James D Griffin

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Transcription Factor

Top Venues

Cell death and differentiation

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Swati Garg, Wei Ni, Basudev Chowdhury, Ellen L Weisberg, Martin Sattler, James D Griffin
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. Cell death and differentiation 31 (7) (2024)
Swati Garg, Wei Ni, Basudev Chowdhury, Ellen L Weisberg, Martin Sattler, James D Griffin
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. Cell death and differentiation 31 (7) (2024)
Swati Garg, Wei Ni, Basudev Chowdhury, Ellen L Weisberg, Martin Sattler, James D Griffin
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. Cell death and differentiation 31 (7) (2024)
Swati Garg, Wei Ni, Basudev Chowdhury, Ellen L Weisberg, Martin Sattler, James D Griffin
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. Cell death and differentiation (2024)
Ellen L Weisberg, Basudev Chowdhury, Chengcheng Meng, Abigail E Case, Wei Ni, Swati Garg, Martin Sattler, Abdel Kareem Azab, Abdel Kareem Azab, Barbara Muz, Dana Sanchez, Anthia Toure, Richard M Stone, Ilene Galinsky, Eric Winer, Scott Gleim, Sofia Gkountela, Alexia Kedves, Edmund Harrington, Tinya Abrams, Thomas Zoller, Andrea Vaupel, Paul Manley, Michael Faller, BoYee Chung, Xin Chen, Philipp Busenhart, Christine Stephan, Keith Calkins, Debora Bonenfant, Claudio R Thoma, William Forrester, James D Griffin
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. Blood cancer journal 12 (7) (2022)
Jing Yang, Ellen L Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S Magin, Laura Doherty, Wenchao Wang, Jing Liu, Sara J Buhrlage, Qing-Song Liu, James D Griffin
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2. Leukemia 36 (4) (2022)
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, Robert S Magin, Wai Cheung Chan, Bin Hu, Nathan J Schauer, Shengzhe Zhang, Ilaria Lamberto, Laura Doherty, Chengcheng Meng, Martin Sattler, Lucia Cabal-Hierro, Eric Winer, Richard Stone, Jarrod A Marto, James D Griffin, Sara J Buhrlage
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia (2021)
Moshe Lapidot, Abigail E Case, Dalia Larios, Helen I Gandler, Chengcheng Meng, Isidora Tošić, Ellen L Weisberg, Michael J Poitras, Prafulla C Gokhale, Cloud P Paweletz, Klaus Podar, Ravi Salgia, Srinivas V Saladi, James D Griffin, David A Frank, Raphael Bueno, Martin Sattler
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM). Cancers 13 (1) (2020)
James D Griffin
Blood's 70th anniversary: arsenic--from poison pill to magic bullet. Blood 127 (14) (2016)